Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05559671
What this trial is testing

Safety of the Herpes Zoster Subunit Vaccine in Lupus

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 224
Early research (Phase 1)Study completedNCT06150651
What this trial is testing

Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.

Who this might be right for
SLE (Systemic Lupus)
Chulalongkorn University 3
Early research (Phase 1)Study completedNCT02852837
What this trial is testing

Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 50
Large-scale testing (Phase 3)Looking for participantsNCT06133972
What this trial is testing

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Who this might be right for
Systemic Lupus Erythematosus
Novartis Pharmaceuticals 550
Post-approval studies (Phase 4)UnknownNCT05666336
What this trial is testing

Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
Fen Li 30
Not applicableLooking for participantsNCT07823400
What this trial is testing

MIECC vs Conventional Cardiopulmonary Bypass and Systemic Inflammation in CABG

Who this might be right for
Coronary Artery DiseaseSystemic Inflammation
Bursa Yuksek Ihtisas Training and Research Hospital 80
Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Who this might be right for
Atopic Dermatitis
Novartis 20
Not applicableEnded earlyNCT03937856
What this trial is testing

Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases

Who this might be right for
Inflammatory ArthritisSclerodermaMyositis+3 more
Johns Hopkins University 49
Early research (Phase 1)Study completedNCT04136145
What this trial is testing

Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 36
Testing effectiveness (Phase 2)Ended earlyNCT02682407
What this trial is testing

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Who this might be right for
IgANLNMN+1 more
Omeros Corporation 31
Large-scale testing (Phase 3)Active Not RecruitingNCT04088396
What this trial is testing

Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Eli Lilly and Company 58
Not applicableUnknownNCT02126098
What this trial is testing

Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis

Who this might be right for
ANCA-associated VasculitisGranulomatosis With PolyangiitisMicroscopic Polyangiitis+1 more
Peking Union Medical College Hospital 100
Early research (Phase 1)Active Not RecruitingNCT04608487
What this trial is testing

Axi-cel in CNS Lymphoma

Who this might be right for
LymphomaLymphoma Cns
Dana-Farber Cancer Institute 18
Large-scale testing (Phase 3)Study completedNCT03160885
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

Who this might be right for
Atopic Dermatitis
LEO Pharma 794
Testing effectiveness (Phase 2)Study completedNCT05430087
What this trial is testing

Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Saiful Anwar Hospital 45
Testing effectiveness (Phase 2)Study completedNCT02939014
What this trial is testing

Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)

Who this might be right for
Hodgkin DiseaseLymphoma, Large-Cell, Anaplastic
Takeda 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07659704
What this trial is testing

CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
University of Sao Paulo 16
Not applicableStudy completedNCT03735238
What this trial is testing

Implementing the Decision-Aid for Lupus (IDEAL Strategy)

Who this might be right for
Systemic Lupus Erythematosus
University of Alabama at Birmingham 1,895
Early research (Phase 1)Study completedNCT01803321
What this trial is testing

Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Regeneron Pharmaceuticals 24
Not applicableStudy completedNCT00341198
What this trial is testing

Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study

Who this might be right for
Autoimmune Disease
National Institute of Environmental Health Sciences (NIEHS) 700
Next Page